Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-01-10 @ 2:30 PM
Study NCT ID:
NCT02303951
Status:
TERMINATED
Last Update Posted:
2021-02-03
First Post:
2014-11-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Vemurafenib + Cobimetinib + Atezolizumab in Melanoma: NEO-VC
Sponsor:
University Hospital Tuebingen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-22
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-14
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-13
First Submit QC Date:
None
Study First Post Date:
2014-12-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-29
Last Update Post Date:
2021-02-03
Last Update Post Date Type:
ACTUAL